Psychoactives MDPI

Psychoactives MDPI Psychoactives is an international, peer-reviewed, open access journal on psychoactive substances.

Read Review "A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying L...
29/05/2026

Read Review "A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens" by Dr. William Roseby and Ms. Catriona Osborn Moar.

Link to read:

Serotonergic psychedelics, particularly psilocybin, lysergic acid diethylamide (L*D), and dimethyltryptamine (DMT), are increasingly recognised as powerful tools to advance the understanding of consciousness and its relation to brain activity. Psychedelic research has informed neuroscientific theori...

Check "A Systematic Review of the Prevalence of Substance Abuse in the South Pacific Region" by Dr. Wole Akosile, Mr. Da...
27/05/2026

Check "A Systematic Review of the Prevalence of Substance Abuse in the South Pacific Region" by Dr. Wole Akosile, Mr. Daniel McDonald, Dr. Henry Aghanwa, and Prof. Bola Ola.

Link to read:

Background: This review examines the prevalence of substance abuse and related disorders in South Pacific nations. Methods: The review focused on data included in reports published since 2000 from countries like Samoa, Papua New Guinea, Fiji, and French Polynesia, excluding Hawaii, New Zealand, Aust...

Read the Review "Cannabis, Extracts, and Individual Phytocannabinoids—All the Same or Substantially Different? A Call fo...
25/05/2026

Read the Review "Cannabis, Extracts, and Individual Phytocannabinoids—All the Same or Substantially Different? A Call for Better Characterization of Cannabis Products" by Dr. Gerhard Nahler.

Link to read:

Cannabis and its derivatives are increasingly popular. The public perception of “cannabis” is commonly related to abuse potential with no sharp distinction to “marijuana”, “cannabinoids”, “hemp”, and cannabis derivatives. Delta 9-tetrahydrocannabinol (THC)—rich cannabis (“marijua...

Read the recently published article "Female Drug Use in the Ethnographic Record: A Cross-Cultural Analysis of Presence, ...
22/05/2026

Read the recently published article "Female Drug Use in the Ethnographic Record: A Cross-Cultural Analysis of Presence, Variation, and Cultural Context" by Mr. Drake Rinks and Prof. Dr. Casey J. Roulette.

Link to read:

Male-biased drug use is a consistent finding in contemporary epidemiology, yet most global evidence derives from urban and industrialized populations. As a result, little is known about gendered substance use in small-scale societies, leaving unresolved whether male-biased drug use reflects universa...

Check recently published Opinion "When Advice Becomes Infrastructure: Ethical Governance of Conversational AI in Psychoa...
20/05/2026

Check recently published Opinion "When Advice Becomes Infrastructure: Ethical Governance of Conversational AI in Psychoactive Substance Information Ecosystems" by Prof. Jaewon Lee.

Link to read:

Public debates about psychoactive substances have traditionally been organized around the pharmacology of compounds and the institutional control of supply. In digitally mediated societies, however, the pathways through which people encounter psychoactives are increasingly informational: search engi...

Check the Case Report "Mitragynine Pseudoindoxyl Withdrawal Treated with Macro-Dosed Buprenorphine Induction: A Case Rep...
18/05/2026

Check the Case Report "Mitragynine Pseudoindoxyl Withdrawal Treated with Macro-Dosed Buprenorphine Induction: A Case Report and Review of the Literature" by Dr. TaReva Warrick-Stone et al.

Link to read: https://brnw.ch/21x2A1j

We invite you to read the Editorial "Psychoactives in 2025: Consolidating an Interdisciplinary Platform for Psychoactive...
15/05/2026

We invite you to read the Editorial "Psychoactives in 2025: Consolidating an Interdisciplinary Platform for Psychoactive Substance Science and Looking to the Future" by our Editor-in-Chief Prof. Dr. Ricardo Dinis-Oliveira.

Link to read:

In 2025, Psychoactives continued its clear upward trajectory, strengthening its position as an international, peer-reviewed, open-access journal dedicated to advancing the science of psychoactive substances, spanning pharmacology, clinical psychiatry, toxicology, neuroscience, forensic science, and ...

We invite you to read the newest published paper, "Psychedelic Use and Missed Needed Mental Health Treatment: Gender Dif...
14/05/2026

We invite you to read the newest published paper, "Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care" by Dr. Sean Matthew Vina.

Link to read:

While prior research links psychedelic use to improved psychological outcomes, less is known about whether psychedelic exposure relates to engagement with formal mental health care when treatment is recognized as needed. Using publicly available, de-identified pooled data from the National Survey on...

Check the newly published paper "The Incongruous Alcohol–Physical Activity Association Reexamined: Veteran and Nonvetera...
05/05/2026

Check the newly published paper "The Incongruous Alcohol–Physical Activity Association Reexamined: Veteran and Nonveteran Outcomes" by Ms. Samantha McCowen, Mrs. Kieleha Ingram, Dr. Julie A. Partridge and Dr. Justin T. McDaniel.

Link to read: https://brnw.ch/21x2cET

Check the new article "Disparities in Synthetic Cannabis Use Among U.S. Adults, 2022–2024" by Prof. Delvon T. Mattingly,...
30/04/2026

Check the new article "Disparities in Synthetic Cannabis Use Among U.S. Adults, 2022–2024" by Prof. Delvon T. Mattingly, Mr. Meman Diaby, Dr. Osayande Agbonlahor and Dr. Joy L. Hart.
Link to read:

Synthetic cannabinoids are widely available in the United States, yet contemporary national data on who uses these products, and disparities in use, are limited. To assess disparities in lifetime and past-year synthetic cannabis use (each yes/no), we used 2022–2024 National Survey on Drug Use and ...

Adresse

Basel

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Psychoactives MDPI erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an Psychoactives MDPI senden:

Teilen

Kategorie